Standard
IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery : Preclinical studies in orthotopic xenografts. / Kurbegovic, Sorel; Juhl, Karina; Sørensen, Kasper Kildegaard; Leth, Julie; Willemoe, Gro Linno; Christensen, Anders; Adams, Yvonne; Jensen, Anja Ramstedt; Von Buchwald, Christian; Skjøth-rasmussen, Jane; Ploug, Michael; Jensen, Knud J.; Kjaer, Andreas.
In:
Theranostics, Vol. 11, No. 15, 2021, p. 7159-7174.
Research output: Contribution to journal › Journal article › peer-review
Harvard
Kurbegovic, S, Juhl, K, Sørensen, KK
, Leth, J, Willemoe, GL
, Christensen, A, Adams, Y, Jensen, AR, Von Buchwald, C, Skjøth-rasmussen, J
, Ploug, M, Jensen, KJ & Kjaer, A 2021, '
IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts',
Theranostics, vol. 11, no. 15, pp. 7159-7174.
https://doi.org/10.7150/thno.49787
APA
Kurbegovic, S., Juhl, K., Sørensen, K. K.
, Leth, J., Willemoe, G. L.
, Christensen, A., Adams, Y., Jensen, A. R., Von Buchwald, C., Skjøth-rasmussen, J.
, Ploug, M., Jensen, K. J., & Kjaer, A. (2021).
IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Theranostics,
11(15), 7159-7174.
https://doi.org/10.7150/thno.49787
Vancouver
Kurbegovic S, Juhl K, Sørensen KK
, Leth J, Willemoe GL
, Christensen A et al.
IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Theranostics. 2021;11(15):7159-7174.
https://doi.org/10.7150/thno.49787
Author
Kurbegovic, Sorel ; Juhl, Karina ; Sørensen, Kasper Kildegaard ; Leth, Julie ; Willemoe, Gro Linno ; Christensen, Anders ; Adams, Yvonne ; Jensen, Anja Ramstedt ; Von Buchwald, Christian ; Skjøth-rasmussen, Jane ; Ploug, Michael ; Jensen, Knud J. ; Kjaer, Andreas. / IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery : Preclinical studies in orthotopic xenografts. In: Theranostics. 2021 ; Vol. 11, No. 15. pp. 7159-7174.
Bibtex
@article{6fbf9bf01ef34906aa0650dfd1ec19f5,
title = "IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts",
author = "Sorel Kurbegovic and Karina Juhl and S{\o}rensen, {Kasper Kildegaard} and Julie Leth and Willemoe, {Gro Linno} and Anders Christensen and Yvonne Adams and Jensen, {Anja Ramstedt} and {Von Buchwald}, Christian and Jane Skj{\o}th-rasmussen and Michael Ploug and Jensen, {Knud J.} and Andreas Kjaer",
year = "2021",
doi = "10.7150/thno.49787",
language = "English",
volume = "11",
pages = "7159--7174",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "15",
}
RIS
TY - JOUR
T1 - IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery
T2 - Preclinical studies in orthotopic xenografts
AU - Kurbegovic, Sorel
AU - Juhl, Karina
AU - Sørensen, Kasper Kildegaard
AU - Leth, Julie
AU - Willemoe, Gro Linno
AU - Christensen, Anders
AU - Adams, Yvonne
AU - Jensen, Anja Ramstedt
AU - Von Buchwald, Christian
AU - Skjøth-rasmussen, Jane
AU - Ploug, Michael
AU - Jensen, Knud J.
AU - Kjaer, Andreas
PY - 2021
Y1 - 2021
U2 - 10.7150/thno.49787
DO - 10.7150/thno.49787
M3 - Journal article
C2 - 34158842
VL - 11
SP - 7159
EP - 7174
JO - Theranostics
JF - Theranostics
SN - 1838-7640
IS - 15
ER -
